Cargando…
Nimodipine Treatment Protects Auditory Hair Cells from Cisplatin-Induced Cell Death Accompanied by Upregulation of LMO4
Ototoxicity is one of the main dose-limiting side effects of cisplatin chemotherapy and impairs the quality of life of tumor patients dramatically. Since there is currently no established standard therapy targeting hearing loss in cisplatin treatment, the aim of this study was to investigate the eff...
Autores principales: | Fritzsche, Saskia, Strauss, Christian, Scheller, Christian, Leisz, Sandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145067/ https://www.ncbi.nlm.nih.gov/pubmed/35628594 http://dx.doi.org/10.3390/ijms23105780 |
Ejemplares similares
-
Nimodipine-Dependent Protection of Schwann Cells, Astrocytes and Neuronal Cells from Osmotic, Oxidative and Heat Stress Is Associated with the Activation of AKT and CREB
por: Leisz, Sandra, et al.
Publicado: (2019) -
Prophylactic nimodipine treatment for hearing preservation after vestibular schwannoma surgery: study protocol of a randomized multi-center phase III trial—AkniPro 2
por: Scheller, Christian, et al.
Publicado: (2021) -
Tabotamp(®), Respectively, Surgicel(®), Increases the Cell Death of Neuronal and Glial Cells In Vitro
por: Leisz, Sandra, et al.
Publicado: (2020) -
Prophylactic nimodipine treatment improves hearing outcome after vestibular schwannoma surgery in men: a subgroup analysis of a randomized multicenter phase III trial
por: Scheller, Christian, et al.
Publicado: (2020) -
Cisplatin-induced apoptosis in auditory, renal, and neuronal cells is associated with nitration and downregulation of LMO4
por: Rathinam, R, et al.
Publicado: (2015)